Protein-primed terminal transferase activity of hepatitis B virus polymerase

Journal of Virology

Volumn 87, Issue 5, 2013, Pages 2563-2576

  Jones, Scott A ^a   Hu, Jianming ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEOTIDE; FOSCARNET; MAGNESIUM; MANGANESE; RNA POLYMERASE; TRANSFERASE;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; COVALENT BOND; DNA SYNTHESIS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME SUBSTRATE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN POLYMERIZATION; PROTEIN PROTEIN INTERACTION; RESIDUE ANALYSIS; REVERSE TRANSCRIPTION; VIRUS PURIFICATION; VIRUS REPLICATION;

DNA PRIMERS; DNA REPLICATION; DNA, VIRAL; HEPATITIS B VIRUS; MANGANESE; RNA, VIRAL; RNA-DIRECTED DNA POLYMERASE; VIRUS REPLICATION;

EID: 84874705088     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02786-12     Document Type: Article

References (81)

1. Lee W. 1997. Hepatitis B virus infection. N. Engl. J. Med. 337:1733-1745.
2. Seeger C, Mason WS. 2000. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64:51- 68.
3. Seeger C, Mason WS, Zoulim F. 2007. Hepadnaviruses, p 2977-3029. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
4. Summers J, Mason WS. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403- 415.
5. Chang LJ, Hirsch RC, Ganem D, Varmus HE. 1990. Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase. J. Virol. 64:5553-5558.
6. Hu J, Seeger C. 1996. Expression and characterization of hepadnavirus reverse transcriptases. Methods Enzymol. 275:195-208.
7. Radziwill G, Tucker W, Schaller H. 1990. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J. Virol. 64:613- 620.
8. Bartenschlager R, Schaller H. 1988. The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J. 7:4185- 4192.
9. Chen Y, Robinson WS, Marion PL. 1994. Selected mutations of the duck hepatitis B virus P gene RNase H domain affect both RNA packaging and priming of minus-strand DNA synthesis. J. Virol. 68:5232-5238.
10. Toh H, Hayashida H, Miyata T. 1983. Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus. Nature 305:827- 829.
11. Xiong Y, Eickbush TH. 1990. Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J. 9:3353- 3362.
12. Lanford RE, Notvall L, Beames B. 1995. Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. J. Virol. 69:4431- 4439.
13. Lanford RE, Notvall L, Lee H, Beames B. 1997. Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase. J. Virol. 71:2996 -3004.
14. Bartenschlager R, Junker-Niepmann M, Schaller H. 1990. The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J. Virol. 64:5324 -5332.
15. Bartenschlager R, Schaller H. 1992. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J. 11:3413-3420.
16. Fallows DA, Goff SP. 1995. Mutations in the epsilon sequences of human hepatitis B virus affect both RNA encapsidation and reverse transcription. J. Virol. 69:3067-3073.
17. Hu J, Boyer M. 2006. Hepatitis B virus reverse transcriptase and epsilon RNAsequences required for specific interaction in vitro. J. Virol. 80:2141- 2150.
18. Hu J, Lin L. 2009. RNA-protein interactions in hepadnavirus reverse transcription. Front. Biosci. 14:1606 -1618.
19. Nassal M, Rieger A. 1996. A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis. J. Virol. 70:2764 -2773.
20. Tavis JE, Perri S, Ganem D. 1994. Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J. Virol. 68:3536 -3543.
21. Wang GH, Seeger C. 1993. Novel mechanism for reverse transcription in hepatitis B viruses. J. Virol. 67:6507- 6512.
22. Beck J, Nassal M. 1998. Formation of a functional hepatitis B virus replication initiation complex involves a major structural alteration in the RNA template. Mol. Cell. Biol. 18:6265- 6272.
23. Beck J, Nassal M. 1997. Sequence- and structure-specific determinants in the interaction between the RNA encapsidation signal and reverse transcriptase of avian hepatitis B viruses. J. Virol. 71:4971- 4980.
24. Tavis JE, Ganem D. 1996. Evidence for activation of the hepatitis B virus polymerase by binding of its RNA template. J. Virol. 70:5741-5750.
25. Tavis JE, Massey B, Gong Y. 1998. The duck hepatitis B virus polymerase is activated by its RNA packaging signal, epsilon. J. Virol. 72: 5789 -5796.
26. Hu J, Seeger C. 1997. RNA signals that control DNA replication in hepadnaviruses. Semin. Virol. 8:205-211.
27. Jones SA, Boregowda R, Spratt TE, Hu J. 2012. In vitro epsilon RNAdependent protein priming activity of human hepatitis B virus polymerase. J. Virol. 86:5134 -5150.
28. Rieger A, Nassal M. 1996. Specific hepatitis B virus minus-strand DNA synthesis requires only the 5' encapsidation signal and the 3'-proximal direct repeat DR1. J. Virol. 70:585-589.
29. Junker-Niepmann M, Bartenschlager R, Schaller H. 1990. A short cisacting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J. 9:3389 -3396.
30. Hu J, Flores D, Toft D, Wang X, Nguyen D. 2004. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J. Virol. 78:13122-13131.
31. Wang GH, Seeger C. 1992. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71:663- 670.
32. Weber M, Bronsema V, Bartos H, Bosserhoff A, Bartenschlager R, Schaller H. 1994. Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J. Virol. 68:2994-2999.
33. Zoulim F, Seeger C. 1994. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J. Virol. 68:6-13.
34. Boregowda R, Adams C, Hu J. 2012. TP-RT domain interactions of duck hepatitis B virus reverse transcriptase in cis and in trans during proteinprimed initiation of DNA synthesis in vitro. J. Virol. 86:6522- 6536.
35. Hu J, Anselmo D. 2000. In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90. J. Virol. 74:11447-11455.
36. Hu J, Seeger C. 1996. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. U. S. A. 93:1060- 1064.
37. Hu J, Toft D, Anselmo D, Wang X. 2002. In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins. J. Virol. 76:269-279.
38. Hu J, Toft DO, Seeger C. 1997. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J. 16:59-68.
39. Stahl M, Beck J, Nassal M. 2007. Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding. J. Virol. 81:13354-13364.
40. Wang X, Hu J. 2002. Distinct requirement for two stages of proteinprimed initiation of reverse transcription in hepadnaviruses. J. Virol. 76: 5857-5865.
41. Wang X, Qian X, Guo HC, Hu J. 2003. Heat shock protein 90- independent activation of truncated hepadnavirus reverse transcriptase. J. Virol. 77:4471- 4480.
42. Lin L, Wan F, Hu J. 2008. Functional and structural dynamics of hepadnavirus reverse transcriptase during protein-primed initiation of reverse transcription: effects of metal ions. J. Virol. 82:5703-5714.
43. Beck J, Nassal M. 2011. A Tyr residue in the reverse transcriptase domain can mimic the protein-priming Tyr residue in the terminal protein domain of a hepadnavirus P protein. J. Virol. 85:7742-7753.
44. Boregowda RK, Lin L, Zhu Q, Tian F, Hu J. 2011. Cryptic protein priming sites in two different domains of duck hepatitis B virus reverse transcriptase for initiating DNA synthesis in vitro. J. Virol. 85:7754- 7765.
45. Urban M, McMillan DJ, Canning G, Newell A, Brown E, Mills JS, Jupp R. 1998. In vitro activity of hepatitis B virus polymerase: requirement for distinct metal ions and the viral epsilon stem-loop. J. Gen. Virol. 79:1121- 1131.
46. Kim HY, Park GS, Kim EG, Kang SH, Shin HJ, Park S, Kim KH. 2004. Oligomer synthesis by priming deficient polymerase in hepatitis B virus core particle. Virology 322:22-30.
47. Nguyen DH, Gummuluru S, Hu J. 2007. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J. Virol. 81:4465- 4472.
48. Lin L, Hu J. 2008. Inhibition of hepadnavirus reverse transcriptaseepsilon RNA interaction by porphyrin compounds. J. Virol. 82:2305- 2312.
49. Cortes Ledesma F, El Khamisy SF, Zuma MC, Osborn K, Caldecott KW. 2009. A human 5'-tyrosyl DNA phosphodiesterase that repairs topoisomerase- mediated DNA damage. Nature 461:674-678.
50. Zeng Z, Cortes-Ledesma F, El Khamisy SF, Caldecott KW. 2011. TDP2/ TTRAP is the major 5'-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase IIinduced DNA damage. J. Biol. Chem. 286:403- 409.
51. Ash DE, Schramm VL. 1982. Determination of free and bound manganese( II) in hepatocytes from fed and fasted rats. J. Biol. Chem. 257:9261- 9264.
52. Bolton EC, Mildvan AS, Boeke JD. 2002. Inhibition of reverse transcription in vivo by elevated manganese ion concentration. Mol. Cell 9:879- 889.
53. Corkey BE, Duszynski J, Rich TL, Matschinsky B, Williamson JR. 1986. Regulation of free and bound magnesium in rat hepatocytes and isolated mitochondria. J. Biol. Chem. 261:2567-2574.
54. Raju B, Murphy E, Levy LA, Hall RD, London RE. 1989. A fluorescent indicator for measuring cytosolic free magnesium. Am. J. Physiol. 256: C540-C548.
55. Romani A, Scarpa A. 1992. Regulation of cell magnesium. Arch. Biochem. Biophys. 298:1-12. 56. Berdis AJ, McCutcheon D. 2007. The use of non-natural nucleotides to probe template-independent DNA synthesis. Chembiochem 8:1399-1408.
56. Berdis AJ, McCutcheon D. 2007. The use of non-natural nucleotides to probe template-independent DNA synthesis. Chembiochem 8:1399-1408.
57. Motea EA, Berdis AJ. 2010. Terminal deoxynucleotidyl transferase: the story of a misguided DNA polymerase. Biochim. Biophys. Acta 1804: 1151-1166.
58. Lue NF, Bosoy D, Moriarty TJ, Autexier C, Altman B, Leng S. 2005. Telomerase can act as a template- and RNA-independent terminal transferase. Proc. Natl. Acad. Sci. U. S. A. 102:9778-9783.
59. Clark JM. 1988. Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases. Nucleic Acids Res. 16:9677-9686.
60. Patel PH, Preston BD. 1994. Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends. Proc. Natl. Acad. Sci. U. S. A. 91:549-553.
61. Poranen MM, Koivunen MR, Bamford DH. 2008. Nontemplated terminal nucleotidyltransferase activity of double-stranded RNA bacteriophage phi6 RNA-dependent RNA polymerase. J. Virol. 82:9254-9264.
62. Ranjith-Kumar CT, Gajewski J, Gutshall L, Maley D, Sarisky RT, Kao CC. 2001. Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependentRNApolymerases: implication for viralRNAsynthesis. J. Virol. 75:8615- 8623.
63. Modak MJ. 1978. Biochemistry of terminal deoxynucleotidyltransferase: mechanism of inhibition by adenosine 5'-triphosphate. Biochemistry 17: 3116-3120.
64. Wang C, Villion M, Semper C, Coros C, Moineau S, Zimmerly S. 2011. A reverse transcriptase-related protein mediates phage resistance and polymerizes untemplated DNA in vitro. Nucleic Acids Res. 39: 7620-7629.
65. Pollack JR, Ganem D. 1993. An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J. Virol. 67:3254-3263.
66. Pollack JR, Ganem D. 1994. Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis. J. Virol. 68:5579-5587.
67. Abraham TM, Loeb DD. 2006. Base pairing between the 5' half of epsilon and a cis-acting sequence, phi, makes a contribution to the synthesis of minus-strand DNA for human hepatitis B virus. J. Virol. 80:4380- 4387.
68. Goldman SR, Ebright RH, Nickels BE. 2009. Direct detection of abortive RNA transcripts in vivo. Science 324:927-928.
69. Hieb AR, Baran S, Goodrich JA, Kugel JF. 2006. An 8 nt RNA triggers a rate-limiting shift of RNA polymerase II complexes into elongation. EMBO J. 25:3100-3109.
70. Kamtekar S, Berman AJ, Wang J, Lazaro JM, de Vega M, Blanco L, Salas M, Steitz TA. 2006. The phi29 DNA polymerase:protein-primer structure suggests a model for the initiation to elongation transition. EMBO J. 25: 1335-1343.
71. Nechaev S, Adelman K. 2011. Pol II waiting in the starting gates: regulating the transition from transcription initiation into productive elongation. Biochim. Biophys. Acta 1809:34-45.
72. Steitz TA. 2006. Visualizing polynucleotide polymerase machines at work. EMBO J. 25:3458-3468.
73. Zahn KE, Tchesnokov EP, Gotte M, Doublie S. 2011. Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase. J. Biol. Chem. 286:25246-25255.
74. Blanca G, Shevelev I, Ramadan K, Villani G, Spadari S, Hubscher U, Maga G. 2003. Human DNA polymerase lambda diverged in evolution from DNA polymerase beta toward specific Mn(++) dependence: a kinetic and thermodynamic study. Biochemistry 42:7467-7476.
75. Seifer M, Standring DN. 1993. Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1. J. Virol. 67:4513- 4520.
76. Kay A, Zoulim F. 2007. Hepatitis B virus genetic variability and evolution. Virus Res. 127:164-176.
77. Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC. 1995. A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 21:273-278.
78. Cao F, Tavis JE. 2004. Detection and characterization of cytoplasmic hepatitis B virus reverse transcriptase. J. Gen. Virol. 85:3353-3360.
79. Yao E, Gong Y, Chen N, Tavis JE. 2000. The majority of duck hepatitis B virus reverse transcriptase in cells is nonencapsidated and is bound to a cytoplasmic structure. J. Virol. 74:8648-8657.
80. Yao E, Tavis JE. 2004. Localization of duck hepatitis B virus polymerase within cells. Methods Mol. Med. 95:281-293.
81. Itzen A, Blankenfeldt W, Goody RS. 2011. Adenylylation: renaissance of a forgotten post-translational modification. Trends Biochem. Sci. 36:221- 228.